Showing 1941-1950 of 5627 results for "".
- US Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Carehttps://modernod.com/news/us-ophthalmologists-push-to-remove-roadblocks-to-patients-access-to-medical-and-surgical-eye-care/2476461/More than 400 eye physicians and surgeons from across the United States are in Washington, DC, to urge Congress to end federal policies that delay patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the American Academy of Ophthalmology (AAO) is
- Chiropractic Treatment and Vision Loss: Examining the Connectionhttps://modernod.com/news/chiropractic-treatment-and-vision-loss-examining-the-connection/2479828/Many Americans visit chiropractors to address pain, often without informing their physicians. And they might not consider eye complications that could result, says Yannis Paulus, MD, a retina specialist at the University of Michigan Kellogg Eye Center. The energetic thrusts and rota
- Novartis: New Analysis of Phase 3 Brolucizumab Data Reinforces Superior Reduction of Retinal Fluidhttps://modernod.com/news/novartis-new-analysis-of-phase-3-brolucizumab-data-reinforces-superior-reduction-of-retinal-fluid/2479846/Novartis announced a new data analysis showing that retinal fluid was detected less often in patients treated with brolucizumab (RTH258) 6 mg versus aflibercept over four visits between weeks 36 to 48[1]. Retinal fluid is a key marker of disease activity in neovascular age-related macular degener
- Nicox Announces Data Collection Complete, NCX 470 Phase 3b Whistler Glaucoma Trialhttps://modernod.com/news/nicox-announces-data-collection-complete-ncx-470-phase-3b-whistler-glaucoma-trial/2482709/Nicox announced today that the last patient completed their final visit in the Whistler phase 3b clinical trial investigating the efficacy of NCX470 to lower IOP. This marks the end of their
- Medicare Sticks With E/M Pay Plan Over Some Groups’ Objectionshttps://modernod.com/news/medicare-sticks-with-e-m-pay-plan-over-some-groups-objections/2478136/The Trump administration is sticking with a plan to boost certain Medicare pay for many primary care and other specialties focused heavily on office visits while lowering that for other groups to balance these increased costs, according to a Medscape
- Analysis: Ophthalmology Lost More Patient Volume Due to COVID-19 Than Any Other Specialtyhttps://modernod.com/news/analysis-55-percent-fewer-americans-sought-hospital-care-in-march-april-due-to-covid-19/2477738/A new large analysis revealed that ophthalmology lost more patient volume due to the COVID-19 pandemic than any other medical specialty. The analysis of over 2 million patient visits and encounters
- Heidelberg Engineering Showcases Technologies to Enhance the Future of Imaging Technology at ARVOhttps://modernod.com/news/heidelberg-engineering-showcases-technologies-to-enhance-the-future-of-imaging-technology-at-arvo/2482771/Heidelberg Engineering announced a portfolio of innovations aimed at redefining image quality, clinical research, and patient care in ophthalmology at ARVO. According to Heidelberg, Chameleon Imaging Research Platform is des
- Glaukos Expands its Preserflo MicroShunt Relationship With Santen Via New License Agreementhttps://modernod.com/news/glaukos-expands-its-preserflo-microshunt-relationship-with-santen-via-new-license-agreement/2479228/Glaukos announced that it has entered into a new development and commercialization license agreement with Santen Pharmaceutical for the Preserflo MicroShunt (development code: DE-128), superseding the previous collaboration and distribution agreements between the two parties. Financial ter
- Discovery of a New Drug for Diabetic Retinopathyhttps://modernod.com/news/discovery-of-a-new-drug-for-diabetic-retinopathy/2478858/A potentially effective treatment for diabetic retinopathy has been developed by an Université de Montréal (UdeM) scientist and investigator at Maisonneuve-Rosemont Hospital Research Centre (MRH-RC). Working with research scientist Pam Tsuruda of the
- Santen to Present Glaucoma/OcularHypertension Data at AAO 2020 Virtualhttps://modernod.com/news/santen-to-present-glaucoma-ocularhypertension-data-at-aao-2020-virtual/2478519/Santen announced that the following talks on glaucoma and ocular hypertension will be presented at the American Academy of Ophthalmology (AAO) Virtual 2020 meeting. Poster Topic: MicroShunt (or DE-128), an investigational surgical glaucoma implant designed to reduce intrao